Results Sixty-two eyes were entered into the
Silicone oil is used in the treatment of complex retinal detachments but late complications such as glaucoma and corneal decompensation are well known. l-4 The removal of silicone oil (ROSO) is advocated to reduce complications over the long term. Once some complications have occurred, such as increased intraocular pressure, they may not be reversible even after silicone oil is removed.1 Risk of recurrent retinal detachment following ROSO is also significant, especially in the presence of proliferative vitreoretinopathy (PVR). 5 , 6 The overall visual benefit of further surgical procedures to reattach the retina in those patients with recurrent detachments has not been studied. We separately evaluated the final visual and anatomical results in this group of patients who developed recurrent retinal detachments following ROSO and underwent further intraocular procedures for retinal reattachment in an attempt to determine whether further surgery on these eyes is beneficial in maintaining ambulatory visual acuity.
It is advocated by some that the use of 3600 indirect laser to the mid-peripheral retina approximately 6 weeks prior to ROSO or at the time of ROSO may decrease the incidence of recurrent retinal detachment. 7 , s There are few prior data supporting this approach and we looked at those patients in our current series who underwent 3600 laser prior to or combined with ROSO.
Methods
Sixty-two consecutive eyes scheduled for routine ROSO following successful retinal attachment surgery over a 1 year time period were entered prospectively into this study. All eyes had been treated with injection of 1000 cS silicone oil.
In addition to the placement of silicone oil, prior vitreoretinal procedures generally consisted of: 18 vitrectomies with intraocular gas tamponade (either SF 6 or C 3 F s ), 5 of which included the placement of a scleral buckle; 15 scleral buckles with cryotherapy; 3 D-ACE (drain, air, cryotherapy, buckle) procedures; 9 and 2 large horseshoe retinal tears treated with laser and/or cryotherapy only. In addition, revision of scleral buckle, membrane peeling and releasing retinotomy and retinectomy were carried out as indicated at the time of the last vitreoretinal procedure. All aphakic and pseudophakic eyes had surgical inferior peripheral iridectomies at the time of the initial placement of silicone oil.
Before silicone oil removal, all eyes had a complete ocular examination which included best-corrected Snellen visual acuity, measurement of intraocular pressure, slit-lamp examination with particular attention to the status of the cornea, lens and location of the silicone oil (anterior or posterior to the plane of the iris), and binocular indirect ophthalmoscopy.
ROSa was carried out for the following reasons: stable eyes with fully attached retina (48 eyes), chronic retinal detachment requiring further vitreoretinal surgery in conjunction with silicone oil removal (2 eyes), possible silicone-oil-related complications such as corneal oedema or ocular hypertension (12 eyes).
ROSa was performed under general or peribulbar anaesthesia utilising a posterior inferotemporal infusion cannula placed in a standard fashion. In phakic eyes, the oil was removed utilising a superior sclerostomy 4.5 mm posterior to the limbus and in aphakic and pseudophakic eyes the oil was removed through a 3 mm circumferential limbal incision. In 14 cases, ROSa was combined with cataract extraction and posterior chamber intraocular lens implantation.
Post-operative topical antibiotics, cycloplegics and corticosteroids were used in a standard fashion and tapered accordingly over a 4-6 week period. Complete ocular examinations including indirect ophthalmoscopy were carried out at 1 day, 1 week, 4 weeks, 3 months and 5 months post-operatively. We followed these eyes for an average of 12 months (range 8 months to 2 years) after ROSa for evidence of recurrent retinal detachment and other complications relating to the silicone oil, including persistent intraocular pressure elevation and corneal decompensation. Twenty-five (44%) of these eyes had silicone oil placed as the primary procedure, while 20 (33%) and had one prior surgical retina procedure. Seventeen (26%) eyes had two or more prior vitreoretinal procedures. Sixty three per cent of eyes (39 total) had silicone oil placed for PVR (grade B2 or worse) and in 11 of these (28%), silicone oil was placed as the primary procedure. In 9 eyes (15%), silicone oil was used for giant retinal tears and 8 of these had primary oil placement. The remaining 14 eyes (22%) had silicone oil for a variety of other reasons which included 2 subretinal haemorrhages from drainage complications during scleral buckling surgery, 4 combined traction/rhegmatogenous retinal detachments, 3 post-traumatic retinal detachments, 3 eyes with multiple breaks in four quadrants, and 2 multiply recurrent vitreous haemorrhages. Six of these 14 eyes had silicone oil placed at the primary vitrectomy. We found no statistically significant association between At the time of ROSa, 11 eyes (18%) had evidence of elevated intraocular pressure prior to silicone oil removal and of these eyes, 4 were aphakic. All 11 eyes had persistently elevated intraocular pressure after silicone oil removal. Three of these 11 eyes developed recurrent retinal detachments; 2 of these 3 eyes were aphakic (eyes 3, 12, 19) ( Table 1 ). Initial lens status included 12 (19%) aphakic eyes, 40 (65%) phakic eyes and 10 (16%) pseudophakic eyes. There was no statistically significant association between initial lens status and either retinal status after ROSa or final retinal status (Fisher exact; p < 0.05). Twenty-one eyes (35%) developed cataracts related to the silicone oil and of these 14 required cataract extraction at the time of silicone oil removal. Six of these 14 eyes (43%) developed recurrent retinal detachment after silicone oil removal. Two eyes had evidence of corneal decompensation or corneal oedema at the time of silicone oil removal. Two eyes had chronic, stable inferior retinal detachments without macular involvement at the time of silicone oil removal. One of these eyes (eye 4) had evidence of reproliferation and is now reattached following another procedure at the time of silicone oil removal with SF 6 gas and without silicone oil replacement ( Table 1 ). The second eye (eye 7), underwent two procedures with oil in situ including retinectomy and endolaser 3 months before ROSa. This eye had ROSa then performed for corneal decompensation and chronic inferior retinal detachment and is now phthisicial with PL vision and no further surgery was felt to be appropriate (Table 1) .
Of the eyes that had silicone oil removed, 21 of 62 had recurrent retinal detachments (34%) ( Table 1 ). This 34% includes the 2 eyes with chronic retinal detachments at the time of the removal of silicone oil (eyes 4 and 7), 3 eyes with elevated intraocular pressure (eyes 3, 12, 19), eye 7 also had corneal decompensation and the remaining 16 eyes in this group were felt to have stable attached retinae prior to ROSa. The length of time from silicone oil removal to recurrent retinal detachment varied from 1 day to 6 months but 18 of 21 redetachments occurred within 1 month of ROSa (86%). Of the 21 recurrent retinal detachments, 20 eyes underwent 1 further procedure to stabilise the retina and 18 of these remain with the retina attached at the last follow-up ( Table 2) . Nine of these 18 attached eyes showed either stabilisation or improved visual acuity compared with the presenting visual acuity (Table 3) . Only 5 of 20 required replacement of silicone oil but these 5 have oil remaining in situ at the last follow-up visit. Twenty-seven eyes did not undergo cataract extraction with ROSa and did not develop recurrent retinal detachment. The visual acuity in this group of eyes prior to silicone oil placement ranged from 6/6 to PL (average CF), while following ROSa the average visual acuity improved to 6/60 (range 6/6 to HM). One patient had no visual acuity recorded in this group due to severe mental retardation.
Five eyes had 360 0 laser performed approximately 6 weeks prior to ROSa (8%) and 1 eye had 360 0 laser performed at the time of ROSa. Four of these eyes remained with the retina attached (66%) and 2 detached (33%).
Visual acuities are summarised in Table 3 . Presenting visual acuities (at the time of the first retinal surgery) ranged from 6/6 to PL (average visual acuity was CF). Visual acuity immediately prior to ROSa ranged from 6/6 to PL (average visual acuity was CF). Post-ROSa visual acuities (representing the final visual acuity at last follow-up visit) ranged from 6/6 to NPL (average visual acuity was CF). Overall, 39 eyes (63%) showed improvement in visual acuity after ROSa at the last follow-up visit, 14 eyes showed worsening of visual acuity and 8 eyes showed no change in visual acuity. Forty-seven eyes (76%) had ambulatory visual acuity of CF or better following the removal of silicone oil at the last follow-up visit. One patient had no visual acuity recorded during his care because he was severely mentally retarded, but by observation while he was hospitalised, he did obtain ambulatory visual acuity following ROSa. Of the eyes with recurrent retinal detachments, 57% (12 of 21 eyes) had ambulatory visual acuity at last follow-up (Fig. 1) . Silicone oil had remained in the eyes from 27 days to 497 days (average 212 days or approximately 7 months). There was no statistically significant change in visual acuity from the presenting visual acuity prior to the first retinal detachment surgery to the final visual acuity at the last follow-up clinic visit (average 1 year after removal of silicone oil) (Fisher exact; p < 0.05); comparable visual acuity was maintained despite multiple surgical procedures. 6 The timing for ROSa is still controversial and varies, depending on the series, from 8 weeks and 12 weeks as advocated by Gonvers8 and Franks and Leaver/ to 6 months as reported in the Silicone Oil Study Report 6,11 to 22 months as advocated by Hoing et al. 5 The timing of the removal does not appear to be correlated with the incidence of recurrent detachment, in our series or in other series. 5 ,1l It is felt that silicone oil should remain in situ until a stable anatomical and functional status has been achieved and presumably the proliferative process has stopped. Such a stable situation is somewhat difficult to assess and is largely based on clinical appearances and surgeon experience. At our institution, we aim to remove silicone oil between 6 weeks and 6 months, depending on the underlying pathology and retinal status. It is removed earlier if any silicone-oil-related complications occur such as early corneal changes or raised intraocular pressure. The mean duration of silicone oil tamponade in our current series was 7 months; this is similar to that reported by the Silicone Study GroupY
The rate of recurrent retinal detachment in previous reports has varied from less than 1% to over 50%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In this current series, we report an incidence of recurrent retinal detachment of 34% but we also note that of the 21 retinae that redetached, 18 (86%) were re-attached with only one additional procedure and only 6 of these cases required re-infusion of silicone oil. This gives an overall success rate of 92%, excluding the patient who refused further surgery and the 5 patients with oil in situ. Of these 18 patients, 10 showed stabilisation or improved visual acuity and only 5 cases still have oil in situ; 12 of these eyes (67%) have maintained functional visual acuity of CF or better. Fourteen of 21 redetachments occurred within 1 week of ROSa and 18 of 21 occurred within 3 weeks of ROSa. Other series have reported that recurrent retinal detachments after ROSa occur within 6 months of the procedure and often within 3 months. 6 ,1l However a recent report by Jonas et alY evaluated the timing of retinal redetachment after ROSa and found that the greatest risk or redetachment was within 50 days of oil removal with the risk decreasing sharply after 3-5 months. The short period of time between the ROSa and recurrent detachment would implicate either residual anterior retinal traction or opening of old breaks that had been tamponaded by the silicone oil, or possibly new breaks from intraocular manipulations. In this particular series, we did not perform extensive intraocular manipulations during ROSa. Zilis et al. 6 postulated that the presence of the large silicone bubble filling most of the posterior cavity could lead to the concentration of proliferative factors at the retinal surface. This would lead to proliferation along the retinal surface which would be very difficult to see with the oil in place. Once the oil was removed, the proliferation would extend, leading to further traction and eventually recurrent detachment. There is also some evidence that silicone oil may stimulate release of mitogenic proliferative factors.12 Elimination of residual preretinal traction at the time of oil removal would also be expected to reduce the risk of redetachment. When necessary, we attempt to remove all residual epiretinal membranes at the time of ROSa. In this current series, no extensive posterior segment intervention was necessary. It may be that reinforcement of the choroidal adhesions either prior to oil removal or at the time of oil removal by indirect laser could decrease the rate of recurrent detachments. In 6 cases, 3600 indirect laser to the mid-peripheral retina was performed prior to or the time of ROSa. Two of these cases redetached. These numbers are too small to appreciate any trends as to the advantages of laser versus potential disadvantages.
There are several potential reasons for our high redetachment rate, not the least important of which is that we are a tertiary referral centre so even the primary detachments referred to us are complicated and this accounts for the high rate of silicone rate placement with the initial surgery. We also are referred detachments that have been initially operated elsewhere and failed. These cases have a high incidence of grade B or higher PVR. In other large-scale studies of silicone oil removal, such as the Silicone Oil Study, they admit that they were highly selective in choosing the eyes which had silicone oil removed. They did not remove oil from eyes that had the most severe PVR prior to oil placement even if the retina remained anatomically attached with oil in situ. In contrast, we do not necessarily use the severity of the pre-oil PVR alone in determining the timing of oil removal. Factors that we consider are the length of time the oil has been in place, the number of prior procedures, the presence of a scleral buckle, whether or not a break was found at the last procedure, adequate treatment of all breaks, presence or absence of retinal traction of detachment, presence of epiretinal proliferation, and presence of hypotony. Unfortunately, with multiple surgeons in a large teaching institution, the authors were not able personally to view each case intra-operatively to determine the cause of the recurrent retinal detachment after ROSa.
As noted in other series, visual acuity improved in the majority of eyes following silicone oil removal.1,1l More patients had ambulatory or better visual acuity after oil removal than had that level of visual acuity before their initial surgical procedure. This has also been reported in other series. 6 ,1l It has been postulated by Zilis et al. 6 that the improvement in visual acuity following ROSa is due to a combination of factors including the slow recovery of the naturally reattached retina, altered optics during silicone oil tamponade with improved refraction after silicone oil removal and possible silicone oil retinal toxicity with improved function after silicone oil removal. If the retina remains attached after successful silicone oil removal, progressive visual acuity loss is rare. We have found that comparable final visual acuity is maintained despite multiple vitreoretinal procedures, thus indicating that all attempts should be made to reattach these retinae even after multiple recurrent retinal detachments.
Other studies have also reported a significant incidence of cataract formation?, 3 Fourteen of our patients underwent cataract extraction at the time of ROSa but 6 (43%) of these patients developed recurrent retinal detachment. A recent series showed no increased incidence of retinal detachment following cataract extraction after retinal detachment surgery,14 but these cases were not necessarily complicated retinal detachments and none involved silicone oil.
Eleven patients (18%) had chronic elevated intraocular pressure following ROSa, which is somewhat less than the rate noted in prior articles.v Other articles did have a larger number of aphakic eyes with silicone oil, which is known to be a risk factor for chronic pressure elevation following oil removal. We had no significant complications related to corneal decompensation or hypotony following silicone oil removal.
Conclusions
We realise the limitations of this study, which includes a wide variety of cases with multiple aetiologies, and acknowledge that the reasons we may not have found statistically significant differences on multiple variables is that the power of the study is too small to demonstrate these differences. However, we feel that we can make several guarded statements based on our data including observation that, following ROSa, stabilisation of visual acuity and improvement of visual function is seen even if recurrent retinal detachment occurs. Most cases of recurrent detachment can be repaired with only one additional procedure, often without the use of silicone oil. The recurrent retinal detachment rate is high and an attempt should be made to discern the aetiology of these recurrent retinal detachments at the time of the detachment repair to determine possible preventive measures in the future. We feel there are definitely limitations to the number of surgeries that should be performed in these cases and clinical judgement should be used in these complicated cases when determining whether it is acceptable from a visual and/ or functional standpoint to proceed with further surgeries.
The use of pre-operative 3600 indirect laser to the mid peripheral retina 6 weeks prior to ROSa may be of benefit in preventing recurrent retinal detachment, but the small numbers in this series preclude our making a definitive suggestion as to its use. Further controlled trials into the use of indirect laser either before silicone oil removal or at the time of removal are currently under way.
